Therapeutic drug monitoring in pharmacovigilance and pharmacotherapy safety

Pharmacopsychiatry

Volumn 44, Issue 6, 2011, Pages 254-258

  Haen, E ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

9 field board; analytical methods; clinical pharmacological comment; dose related reference range; drug safety; HPLC; KONBEST; laboratory information management system (LIMS); pharmacotherapy safety; pharmacovigilance; quantification of drug concentration; TDM; therapeutic reference range; UHPLC

Indexed keywords

CLINICAL PHARMACOLOGY; DRUG INDUSTRY; DRUG MARKETING; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOSPITAL INFORMATION SYSTEM; HUMAN; INFORMATION TECHNOLOGY; INTERNET; MASS SPECTROMETRY; PHOTOMETRY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

COMPUTERS; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOVIGILANCE; SOFTWARE;

EID: 80053385948     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0031-1286285     Document Type: Review

References (19)

1. Berthold H, Schott G, Mller-Oerlinghausen B. und die Arzneimittelkommission der deutschen rzteschaft Pharmakovigilanz: Empfehlungen zur Meldung unerwnschter Arzneimittelwirkungen durch die rzteschaft. Arzneiverordnung in der Praxis: 2005; 32 Supp. 1 4 29
2. BMG (Bundesministerium fr Gesundheit, German Federal Ministry of Health): 63b, Gesetz ber den Verkehr mit Arzneimitteln (Arzneimittelgesetz, AMG) in der Fassung der Bekanntmachung vom 12.12.2005 (BGBl. I S. 3394), zuletzt gendert durch Artikel 1 des Gesetzes zur nderung arzneimittelrechtlicher und anderer Vorschriften vom 17. Juli 2009 (BGBl. I S. 1990)
3. Dandliker W B, Feigen G A. Quantification of the Antigen-Antibody- Reaction by the Polarization of Fluorescence. Biochem Res Comm: 1961; 5 299 304
4. Fallas M M, Neue U D, Hadley M R et al. Further investigations of the effect of pressure on retention in ultra-high-pressure liquid chromatography. J Chromatogr A: 2010; 1217 276 284
5. th edition 2005, p 78
6. German Medical Association Professional Code for Physicians in Germany (Musterberufsordnung fr die deutschen rztinnen und rzte, MBO) as adopted by the 100th German Medical Assembly and amended by the 103rd German Medical Assembly, the 105th German Medical Assembly, the 106th German Medical Assembly, the 107th German Medical Assembly and the Resolution of the Council of the German Medical Association of 24.11.2006.
7. Greiner C, Haen E. Therapeutisches Drug Monitoring in der Psychiatrie Erstellung von Referenzbereichen fr die Dosis-Konzentrations-Beziehung. Psychiat Prax: 2007; 34 S90 S92 (Pubitemid 46391906)
8. Greiner C, Haen E. Development of a Simple Column-Switching High-Performance Liquid Chromatography (HPLC) Method for Rapid and Simultaneous Routine Serum Monitoring of Lamotrigine, Oxcarbazepine and 10- Monohydroxycarbazepine (MHD). J Chromatogr B: 2007; 854 338 344 (Pubitemid 46962369)
9. Greiner C, Hiemke C, Bader W et al. Determination of Citalopram and Escitalopram together with Their Active Main Metabolites Desmethyl(es-) citalopram in Human Serum by Column-Switching High Performance Liquid Chromatography (HPLC) and Spectrophotometric Detection. J Chromatogr B: 2007; 848 391 394 (Pubitemid 46453308)
10. Grohmann R, Rther E, Schmidt L G. Unerwnschte Wirkungen von Psychopharmaka: Ergebnisse der AMP-Studie. Springer Verlag Berlin: 1994
11. Haen E, Gpfert C. Cytochrom-P450-Interaktionstabelle. accessible via www.amuep-agate.de Arzneimittelinformationsdienst Cytochrom-P450- Interaktionstabelle
12. Haen E. AGATE: Qualittssicherung in der Psychopharmakotherapie. Neurotransmitter. 2004; 15 7/8 34 43
13. Haen E. Bedeutung der klinisch-pharmakologischen Befundung von Wirkstoffkonzentrationsmessungen zur Therapieleitung. Psychopharmakotherapie: 2005; 12 138 143
14. Haen E, Greiner C, Bader W et al. Wirkstoffkonzentrationsbestimmungen zur Therapieleitung Ergnzung therapeutischer Referenzbereiche durch dosisbezogene Referenzbereiche. Der Nervenarzt: 2008; 79 558 566
15. Kalili K M, de Villiers A. Recent developments in the HPLC separation of phenolic compounds. J Sep Sci: 2011; 34 854 876
16. Kstlbacher A, Haen E. Konbest A Web-Based Laboratory Information Management System (LIMS) for TDM-Laboratories. Pharmacopsychiatry: 2008; 41 212
17. Rao M L, Staberock U, Baumann P et al. Monitoring tricyclic antidepressant concentrations in serum by fluorescence polarization immunoassay compared with gas chromatography and HPLC. Clin Chem: 1994; 40 929 933 (Pubitemid 24166312)
18. Roche Diagnostics GmbH, Mannheim/Germany Carbamazepine detected by COBAS INTEGRA 400/700/800. Method information sheet: 2008
19. Roche Diagnostics GmbH, Mannheim/Germany. Valproic Acid detected by COBAS INTEGRA 400/700/800. Method information sheet: 2008.